This information found on this webpage plus the ACGME Program Requirements for Residency Education in Allergy and Immunology comprise the goals and objectives for the University of Washington Residency Training Program in Allergy and Immunology (A&I).
Years 1 and 2 are divided between clinical, research and other educational activities in a 50/25/25 manner as mandated by the ACGME Residency Review Committees (RRC) for A&I and fulfill ABAI certification requirements.
Our goals are:
- To prepare specialists who provide expert medical care for patients with allergic and immunologic disorders and who can serve as consultants, educators, and physician scientists in asthma, allergic disorders, immunologic disorders, and immunodeficiency diseases.
- To provide A&I fellows with cross-training in both pediatric and adult allergic and immunologic disorders because specialists in allergy and immunology, whatever, their primary specialty, are called on to diagnose and treat individuals of all ages.
- To raise awareness of the limitations of present knowledge and to stimulate an attitude of spirited discussion, acquisition, and sharing of new knowledge, and to formulate questions as hypotheses subject to scientific testing.
The following disease states are covered in depth:
- Upper airway disorders – rhinitis, sinusitis, nasal polyps
- Anaphylaxis/anaphylactoid reactions
- Adverse drug reactions
- Adverse reactions to food/food additives
- Stinging insect reactions
- Atopic dermatitis
- Contact dermatitis
- Primary & secondary immunodeficiences
- Other hypersensitivity disorders – allergic bronchopulmonary aspergillosis, hypersensitivity pneumonitis, disorders of occupational exposure, autoimmune disorders, ocular allergic diseases, mastocytosis, and eosinophilic disorders
Fellow experience with patients having the following disorders is strongly encouraged:
- autoimmune disease
- bronchopulmonary aspergillosis
- eosinophilic disorders
- hypersensitivity pneumonitis
- mastocytosis, ocular allergies
- occupational lung disease • vasculitis.
These goals can be achieved by patient contact, lectures, and/or reading. The fellow will develop skills in skin testing, pulmonary function testing, immunotherapy, and other A&I procedures as described in the Program Requirements for Residency in Allergy and Immunology. The knowledge base presented to fellows will include the etiology, immunopathogenesis, differential diagnosis, therapy, and complications of those A&I diseases listed above.
The following knowledge areas are included in the educational program:
- Knowledge of aerobiology; cellular and molecular immunobiology; humoral and cellular immunology; pulmonary physiology; mechanisms of inflammation; pharmacology and pharmacokinetics, drug metabolism, drug side effects, and drug interactions; the scientific basis of the methodology, indications, and interpretation of laboratory tests and imaging procedures used in the diagnosis and follow up of patients with asthma, allergic, and immunologic and other diseases; preparation and standardization of allergen extracts; means to measure indoor allergens and institution of environmental control measures in the home and other sites; transplantation medicine and tumor immunology; reproductive immunology; the costs of therapy and diagnostic testing; and the psychological effects of chronic illness.
- Knowledge of applied immunology, to include the principles and techniques of clinical immunology laboratory procedures such as tests for humoral immunity, cellular immunity, neutrophil function, cytokines, immune complexes, cryoprecipitable proteins, total serum complement activity and individual complement components, and histocompatibility, as well as procedures for the preparation and use of monoclonal antibodies.
- Knowledge of the etiology, immunopathogenesis, differential diagnosis, therapy, and complications of those diseases referenced in ACGME Program Requirements.
- Knowledge of controversial or unproven drug or therapeutic techniques in allergy, asthma, allergic disorders, immunologic disorders, and immunodeficiency diseases.